The present invention relates to novel tris(hetero)arylpyrazoles, to processes for preparation thereof, to the use thereof for treatment and/or prophylaxis of diseases and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially of retroviral disorders, in man and/or animals.